Home

Mark Schoenberg, Chief Medical Officer: UroGen Pharma URGN Sell · Filed 02/04

Trade details

Type
Insider sale
Amount
$72,577.34
Shares · price
3,686 sh · $19.69 a share
Held after
144,985 sh
Trade date
26/02/03
Filed
26/02/04
Days to filing
1 days

Sold 2.5% of holdings

Share of holding sold
2.5%

UroGen Pharma trades, last 26 weeks

What else happened in UroGen Pharma around then

Filed or reported within 30 days of the trade day · 01/04~03/05

Mark Schoenberg's recent trades

  • Mark Schoenberg

    Planned saleUroGen Pharma

    $38.4K

    Filed 09/09

  • Mark Schoenberg

    Planned saleUroGen Pharma

    $2.9M

    Filed 08/20

  • Mark Schoenberg

    Planned sale10b5-1 planUroGen Pharma

    $400K

    Filed 07/09

  • Mark Schoenberg

    Sell10b5-1 planUroGen Pharma

    $350.1K

    Filed 06/24

  • Mark Schoenberg

    Planned sale10b5-1 planUroGen Pharma

    $350.1K

    Filed 06/22

Mark Schoenberg, Chief Officer — sold $72.6K of UroGen Pharma URGN · 2.5% of holdings | Whalegun